Uricaemia as a surrogate endpoint in gout trials and the treat-to-target approach for gout management

被引：1
|
作者：
Bardin, Thomas [1 ,2 ]
Richette, Pascal [3 ,4 ]
机构：
[1] Univ Paris, INSERM, U1132, F-75010 Paris, France
[2] Inst Mutualiste Montsouris, Dept Med, Paris, France
[3] Hop Lariboisiere, APHP Paris Nord, Dept Rheumatol, Paris, France
[4] Univ Paris, INSERM, U1132, Paris, France
来源：
LANCET RHEUMATOLOGY | 2022年 / 4卷 / 01期
关键词：
D O I：
10.1016/S2665-9913(21)00358-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：E7 / E8
页数：2
相关论文
共 50 条
  • [21] GOUT: SHOULD WE TREAT TO TARGET?
    Richette, Pascal
    RHEUMATOLOGY, 2013, 52 : 1 - 1
  • [22] GOUT FLARES BECOME INFREQUENT DURING A TREAT-TO-TARGET STRATEGY OVER ONE YEAR: DATA FROM THE NOR-GOUT STUDY
    Uhlig, Till
    Karoliussen, Lars Fridtjof
    Haavardsholm, Espen A.
    Kvien, Tore K.
    Hammer, Hilde Berner
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1314 - 1315
  • [23] Gout Flares Become Infrequent During a Treat-to-target Strategy over One Year: Data from the NOR-Gout Study
    Uhlig, Till
    Karoliussen, Lars Fridtjof
    Haavardsholm, Espen A.
    Kvien, Tore
    Hammer, Hilde
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [24] SUCCESSFUL TREATMENT OF GOUT IS FREQUENT IN CLINICAL PRACTICE WHEN APPLYING A TREAT-TO-TARGET STRATEGY: RESULTS FROM THE NOR-GOUT STUDY
    Uhlig, T.
    Karoliussen, L. F.
    Kvien, T. K.
    Haavardsholm, E. A.
    Hammer, H. Berner
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 456 - 456
  • [25] Treat-to-target (T2T) of serum urate (SUA) in gout: a clinical audit in real-world gout patients
    Teh, C. L.
    Cheong, Y. K.
    Wan, S. A.
    Ling, G. R.
    REUMATISMO, 2019, 71 (03) : 154 - 159
  • [26] Course and predictors of work productivity in gout - results from the NOR-Gout longitudinal 2-year treat-to-target study
    Uhlig, Till
    Karoliussen, Lars F.
    Sexton, Joe
    Provan, Sella Aarrestad
    Kvien, Tore K.
    Haavardsholm, Espen A.
    Hammer, Hilde Berner
    RHEUMATOLOGY, 2023, 62 (12) : 3886 - 3892
  • [27] Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study
    Uhlig, Till
    Karoliussen, Lars Fridtjof
    Sexton, Joseph
    Kvien, Tore K.
    Haavardsholm, Espen A.
    Hammer, Hilde Berner
    RMD OPEN, 2023, 9 (04):
  • [28] Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
    Hammer, Hilde Berner
    Karoliussen, Lars
    Terslev, Lene
    Haavardsholm, Espen A.
    Kvien, Tore K.
    Uhlig, Till
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (11) : 1500 - 1505
  • [29] Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice
    Fernando Perez Ruiz
    Carlos A. Sanchez-Piedra
    Jesus T. Sanchez-Costa
    Mariano Andrés
    Cesar Diaz-Torne
    Mercedes Jimenez-Palop
    Eugenio De Miguel
    Carmen Moragues
    Francisca Sivera
    Rheumatology and Therapy, 2018, 5 : 243 - 253
  • [30] Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice
    Perez Ruiz, Fernando
    Sanchez-Piedra, Carlos A.
    Sanchez-Costa, Jesus T.
    Andres, Mariano
    Diaz-Torne, Cesar
    Jimenez-Palop, Mercedes
    De Miguel, Eugenio
    Moragues, Carmen
    Sivera, Francisca
    RHEUMATOLOGY AND THERAPY, 2018, 5 (01) : 243 - 253
12345